# FDA 483 - Jing Zhou Hou, MD, PhD - October 12, 2018

Source: https://www.keypedia.com/records/483/jing-zhou-hou-md-phd/06933539-b252-4112-bfb3-d6e7970ab8ff

> FDA 483 for Jing Zhou Hou, MD, PhD on October 12, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jing Zhou Hou, MD, PhD
- Inspection Date: 2018-10-12
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Jing Zhou Hou, MD, PhD, a clinical investigator in Pittsburgh, PA, revealed significant deficiencies in the conduct of an investigational study. Observations included failure to follow the investigational plan, delayed reporting of unanticipated problems to the IRB, and inadequate maintenance of case histories. These issues suggest a lack of proper oversight and adherence to regulatory requirements in clinical trial management.

## Related Officers

- [Cynthia L. Rakestraw](https://www.keypedia.com/people/cynthia-l-rakestraw/ca138abf-e5d4-43ca-b9d2-79ea6294a8c8)

Company: https://www.keypedia.com/companies/jing-zhou-hou-md-phd/c6789c19-d674-4f10-9df6-ddfab5e2cfbc

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8